Preferred Label : Sulfonylurea Antidiabetic Agent;

NCIt synonyms : Sulphonylurea Antidiabetic Agent;

NCIt related terms : Sulfonylurea;

NCIt definition : Sulfonamide urea derivatives with antihyperglycemic activity. Sulphonylurea antidiabetic agents bind to sulfonylurea receptor type 1 (SUR1), the subunit of ATP-sensitive inwardly-rectifier potassium (IKATP) channels on the membranes of pancreatic beta cells, thereby blocking the inward current flow (influx) of positively charged K ions into the cell. This results in tonic membrane depolarization, and induces a calcium ion influx through voltage-sensitive calcium channels; increased intracellular calcium ion levels trigger exocytosis of insulin-containing granules. This eventually induces secretion of insulin. The IKATP channels found in pancreatic islets are complexes of four IKATP 6.2 and four SUR1 subunits. In addition, some sulfonylureas of larger molecular size may increase the sensitivity of peripheral tissues to insulin mediated through peroxisome proliferator-activated receptor gamma (PPARgamma).;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


http://www.cfp.ca/content/64/4/296
2018
false
false
false
Canada
French
diabetes mellitus, type 2
cardiovascular diseases
treatment outcome
Evidence-Based medicine
hypoglycemic agents
sulfonylurea compounds
cardiovascular diseases
Sulfonylurea Antidiabetic Agent
journal article

---
Nous contacter.
28/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.